Physician Assistant Clinical Knowledge Rating And Assessment Tool (PACKRAT) 1 Practice Exam

Long-term Crohn’s disease management centers on reducing the immune-driven inflammation with immunomodulators or biologic therapies to maintain remission. 5-fluorouracil is a chemotherapy agent used to treat cancer by targeting rapidly dividing cells; it does not reliably alter the inflammatory pathways in Crohn’s and has significant mucosal toxicity, making it unsuitable for chronic Crohn’s therapy. Azathioprine, in contrast, suppresses the immune system to prevent relapses, and is a standard maintenance option for Crohn’s disease. Omeprazole, a proton-pump inhibitor, lowers stomach acid and can help with unrelated GI symptoms or ulcers but doesn’t address Crohn’s inflammation itself. Allopurinol treats hyperuricemia/gout and isn’t a Crohn’s therapy; though it has notable drug interaction considerations with immunosuppressants like azathioprine, it still isn’t used to manage Crohn’s disease. So, the medication not typically used for long-term Crohn’s disease therapy is 5-fluorouracil.